Nirogi R, Kandikere V, Mudigonda K, Bhyrapuneni G, Jasti V. Safety, tolerability and pharmacokinetics of SUVN-502 - A 5-HT6 receptor antagonist, first in human phase-1 Single Ascending Dose (SAD) study. July 2009, Volume 5, Issue 4, Supplement, Page P250
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.